| Dr Brett Eisenmesser, MD | |
|
1600 Medical Pkwy, Ctrmc, Carson City, NV 89703-4625 | |
| (775) 445-8733 | |
| Not Available |
| Full Name | Dr Brett Eisenmesser |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Experience | 29 Years |
| Location | 1600 Medical Pkwy, Carson City, Nevada |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1427019009 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | 10419 (Nevada) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Carson Tahoe Regional Medical Center | Carson city, NV | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Carson Tahoe Emergency Physicians | 7416930573 | 24 |
News Archive
Takeda Pharmaceutical Company Limited ("Takeda") today announced that its wholly owned subsidiary, Takeda Global Research & Development Center, Inc. (U.S.), received on September 2 (U.S. TIME), a complete response letter from the U.S. Food and Drug Administration (FDA) regarding the New Drug Application (NDA) for the fixed-dose combination (FDC) of alogliptin and ACTOS(R) (pioglitazone HCl).
Among African Americans, HIV infection is increasingly recognized as an important risk factor for developing chronic kidney disease. African American men and women are more likely to die from the complications of HIV infection compared with Caucasian men and women.
T2 Biosystems, a company developing direct detection products enabling superior diagnostics, today announced the presentation of new data on hemostasis monitoring at the American Association for Clinical Chemistry Annual Meeting, July 15-19, 2012, in Los Angeles, CA.
WHO member states meeting in Seoul, South Korea, on Monday unanimously approved a new international treaty to combat the illegal tobacco trade, VOA News reports.
› Verified 4 days ago
| Entity Name | Carson Tahoe Emergency Physicians |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1396822821 PECOS PAC ID: 7416930573 Enrollment ID: O20040609001476 |
News Archive
Takeda Pharmaceutical Company Limited ("Takeda") today announced that its wholly owned subsidiary, Takeda Global Research & Development Center, Inc. (U.S.), received on September 2 (U.S. TIME), a complete response letter from the U.S. Food and Drug Administration (FDA) regarding the New Drug Application (NDA) for the fixed-dose combination (FDC) of alogliptin and ACTOS(R) (pioglitazone HCl).
Among African Americans, HIV infection is increasingly recognized as an important risk factor for developing chronic kidney disease. African American men and women are more likely to die from the complications of HIV infection compared with Caucasian men and women.
T2 Biosystems, a company developing direct detection products enabling superior diagnostics, today announced the presentation of new data on hemostasis monitoring at the American Association for Clinical Chemistry Annual Meeting, July 15-19, 2012, in Los Angeles, CA.
WHO member states meeting in Seoul, South Korea, on Monday unanimously approved a new international treaty to combat the illegal tobacco trade, VOA News reports.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Brett Eisenmesser, MD 1600 Medical Pkwy, Ctrmc, Carson City, NV 89703-4625 Ph: (775) 445-8733 | Dr Brett Eisenmesser, MD 1600 Medical Pkwy, Ctrmc, Carson City, NV 89703-4625 Ph: (775) 445-8733 |
News Archive
Takeda Pharmaceutical Company Limited ("Takeda") today announced that its wholly owned subsidiary, Takeda Global Research & Development Center, Inc. (U.S.), received on September 2 (U.S. TIME), a complete response letter from the U.S. Food and Drug Administration (FDA) regarding the New Drug Application (NDA) for the fixed-dose combination (FDC) of alogliptin and ACTOS(R) (pioglitazone HCl).
Among African Americans, HIV infection is increasingly recognized as an important risk factor for developing chronic kidney disease. African American men and women are more likely to die from the complications of HIV infection compared with Caucasian men and women.
T2 Biosystems, a company developing direct detection products enabling superior diagnostics, today announced the presentation of new data on hemostasis monitoring at the American Association for Clinical Chemistry Annual Meeting, July 15-19, 2012, in Los Angeles, CA.
WHO member states meeting in Seoul, South Korea, on Monday unanimously approved a new international treaty to combat the illegal tobacco trade, VOA News reports.
› Verified 4 days ago
Dr. Sara M Ream, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1600 Medical Pkwy, Carson City, NV 89703 Phone: 775-445-8000 | |
Dr. Pacharin Noraseat, MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 1201 S Carson Street, Suite 1104, Carson City, NV 89701 Phone: 775-445-7330 Fax: 775-841-1139 | |
Maurice A. Mayer, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1600 Medical Pkwy, Carson City, NV 89703 Phone: 775-445-8005 | |
Andrew Doering, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1600 Medical Pkwy, Carson City, NV 89703 Phone: 775-445-8000 | |
David J. Strull, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1600 Medical Pkwy, Carson City, NV 89703 Phone: 775-445-8005 | |
Kerry W. Novak, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1600 Medical Pkwy, Carson City, NV 89703 Phone: 775-445-8005 |